BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 8122950)

  • 1. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
    Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
    AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus (CMV) titers among acquired immunodeficiency syndrome (AIDS) patients with and without a history of Kaposi's sarcoma (KS).
    Johnston GS; Jockusch J; McMurtry LC; Shandera WX
    Cancer Detect Prev; 1990; 14(3):337-42. PubMed ID: 2167170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
    Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
    AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors associated with survival in Kaposi's sarcoma in patients infected with the human immunodeficiency virus. Clinical Epidemiological Group for AIDS in Aquitaine].
    Cazorla C; Dabis F; Dupon M; Ragnaud JM; Geniaux M; Pellegrin JL; Salmi LR
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):109-17. PubMed ID: 10367298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of the survival benefit of zidovudine therapy in HIV infection.
    Moore RD; Keruly JC; Chaisson RE
    Arch Intern Med; 1996 May; 156(10):1073-7. PubMed ID: 8638994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
    N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Gill PS
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Kaposi's sarcoma.
    Beral V
    Cancer Surv; 1991; 10():5-22. PubMed ID: 1821323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
    Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
    Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
    Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
    J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma: a reevaluation.
    Orfanos CE; Husak R; Wölfer U; Garbe C
    Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.